| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/LARY.25320 |
| P698 | PubMed publication ID | 25892161 |
| P2093 | author name string | Todd T Kingdom | |
| Brett W Davies | |||
| Vikram D Durairaj | |||
| P2860 | cites work | "Balanced" orbital decompression for severe Graves' orbitopathy: technique with treatment algorithm | Q35071629 |
| A systematic review of outcomes following surgical decompression for dysthyroid orbitopathy. | Q37439618 | ||
| Comparison of lateral and medial orbital decompression for the treatment of compressive optic neuropathy in thyroid eye disease | Q37782247 | ||
| Graded orbital decompression based on severity of proptosis | Q39405494 | ||
| Strabismus after balanced medial plus lateral wall versus lateral wall only orbital decompression for dysthyroid orbitopathy | Q41752178 | ||
| Strabismus after inferior-medial wall orbital decompression in thyroid-related orbitopathy. | Q43663148 | ||
| Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures | Q46083146 | ||
| Primary-gaze diplopia in patients with thyroid-related orbitopathy undergoing deep lateral orbital decompression with intraconal fat debulking: a retrospective analysis of treatment outcome | Q46174774 | ||
| Orbital decompression for thyroid-associated orbitopathy in England: trends over time and geographical variation. | Q51232684 | ||
| Orbital fat removal. Decompression for Graves orbitopathy. | Q51664950 | ||
| Transconjunctival fat removal combined with conservative medial wall/floor orbital decompression for Graves orbitopathy. | Q53353546 | ||
| Balanced orbital decompression combined with fat removal in Graves ophthalmopathy: do we really need to remove the third wall? | Q53656516 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 2034-2040 | |
| P577 | publication date | 2015-04-17 | |
| P1433 | published in | The Laryngoscope | Q15755068 |
| P1476 | title | Orbital decompression for the management of thyroid eye disease: An analysis of outcomes and complications | |
| P478 | volume | 125 |
| Q57283980 | Q57283980 |
| Q57283996 | Q57283996 |
| Q46406814 | Abducens nerve palsy after orbital decompression |
| Q91865086 | Augmented endoscopic orbital apex decompression in dysthyroid optic neuropathy |
| Q48584603 | Balanced (endoscopic medial and transcutaneous lateral) orbital decompression in Graves' orbitopathy. |
| Q26800562 | Critical Appraisal on Orbital Decompression for Thyroid Eye Disease: A Systematic Review and Literature Search |
| Q55001461 | Cutting-edge endonasal surgical approaches to thyroid ophthalmopathy. |
| Q92983927 | Influence of orbital morphology on proptosis reduction and ocular motility after decompression surgery in patients with Graves' orbitopathy |
| Q39159003 | Orbital Decompression for Thyroid Eye Disease |
| Q49829361 | Orbital decompression for thyroid eye disease: methods, outcomes, and complications. |
| Q52606254 | Original endoscopic orbital decompression of lateral wall through hairline approach for Graves' ophthalmopathy: an innovation of balanced orbital decompression. |
| Q50967696 | Preoperative clinical features of reactivated of Graves' orbitopathy after orbital decompression. |
| Q45157144 | Surgical Freedom Evaluation During Optic Nerve Decompression: Laboratory Investigation |
| Q38979463 | Surgical complications in orbital decompression for Graves' orbitopathy. |
| Q93333216 | Tocilizumab for thyroid eye disease |
| Q94355143 | Tocilizumab for thyroid eye disease |
Search more.